EZHIP and H3K27me3 are useful diagnostic markers for germinoma and for the germinoma component of germ cell tumors of central nervous system [0.03%]
EZHIP和H3K27me3是诊断生殖细胞瘤及中枢神经系统生殖细胞肿瘤中生殖细胞瘤成分的有用标志物
Lu Han,Zeliang Hu,Lihong Zhao et al.
Lu Han et al.
Background: Differentiating central nervous system (CNS) germinomas from other germ cell tumors (GCTs) is diagnostically challenging. EZHIP (EZH Inhibitory Protein, encoded by CXorf67) and H3K27me3 (trimethylated histone ...
Living with brain metastases-A longitudinal qualitative study of patient experiences from time of diagnosis [0.03%]
脑转移瘤患者的经历——一项关于诊断后的纵向质性研究
Tonje Lundeby,Asta Bye,Olav Eric Yri et al.
Tonje Lundeby et al.
Background: Brain metastases (BM) are prevalent intracranial neoplasms in adults, affecting 20%-40% of cancer patients. With improved systemic therapies and neuroimaging, the frequency of BM diagnoses is rising. Despite a...
BRAF-MEK inhibition in a giant BRAF-mutant Rathke cleft cyst: Diagnostic challenges and clinical implications for BRAF testing [0.03%]
BRAF-MEK抑制在巨大型BRAF突变垂体裂囊肿中的应用:诊断挑战及BRAF检测的临床意义
Bertrand Baussart,Delphine Leclercq,Carine Courtillot et al.
Bertrand Baussart et al.
Background: Rathke cleft cysts are benign sellar lesions with a substantial risk of postoperative recurrence. In contrast to papillary craniopharyngiomas, oncogenic BRAF mutations are exceptionally reported in Rathke clef...
Joshua Woo,Luciana M Santillana Linares,Sean C Holden-Kapshuck et al.
Joshua Woo et al.
Background: Nigeria, the most populous country in Africa, has the highest incidence of central nervous system (CNS) tumors on the continent, yet faces limited access to neuro-oncology care, particularly for pediatric pati...
Tumor boundary delineation in IDH-wildtype glioblastoma: A prospective comparative analysis of 11C-MET PET and FLAIR MRI in surgical decision-making [0.03%]
IDH野生型胶质母细胞瘤的肿瘤边界界定:在手术决策中比较分析11C-MET正电子发射断层扫描与FLAIR磁共振成像的一项前瞻性研究
Maria Pia Tropeano,Zefferino Rossini,Andrea Pizzi et al.
Maria Pia Tropeano et al.
Background: Supramaximal resection (SUPR) in IDH-wildtype glioblastoma (GBM) aims to improve survival by extending resection beyond contrast-enhancing lesions into non-enhancing FLAIR-hyperintense regions. The role of met...
Buprenorphine for the treatment of pain in patients with central nervous system tumors: A case series [0.03%]
布酚宁治疗中枢神经系统肿瘤患者的疼痛:病例系列研究
John Y Rhee,Paul Miller,Alexander Finnemore et al.
John Y Rhee et al.
Background: Patients with CNS tumors have high rates of chronic cancer pain and headache but are more sensitive to cognitive and sedation side effects from full-opioid agonists. Buprenorphine, a partial opioid agonist, of...
Comparison of temporal muscle indices for survival prediction in patients with glioblastoma: Prognostic value, accuracy and reliability [0.03%]
比较颞肌指数在胶质母细胞瘤患者生存预测中的价值、准确性和可靠性
Emilia K Pesonen,Otso Arponen,Jaakko Niinimäki et al.
Emilia K Pesonen et al.
Background: Temporal muscle thickness (TMT) and cross-sectional area (TMA) are readily available estimates of whole-body muscle mass. Low TMT and TMA have been associated with increased mortality in various neurological d...
The effectiveness of targeted therapy in the treatment of patients with neurofibromatosis type 2-related schwannomatosis and vestibular schwannomas: A systematic review [0.03%]
靶向治疗神经纤维瘤病2型相关施万细胞瘤和前庭神经鞘瘤的有效性:系统评价
Hala Rahman,Mithum Senaratne,Mona Ajal Loueian et al.
Hala Rahman et al.
Background: Neurofibromatosis type 2-related schwannomatosis (NF2-SWN) is a rare genetic tumor syndrome causing progressive neurological morbidity. This systematic review evaluates current evidence on the effectiveness, s...
Natural history study of adults with primary central nervous system tumors: Initial results for first 1000 participants [0.03%]
原发中枢神经系统肿瘤成人患者的自然病史研究:前1000名参与者的结果
Kimberly R Robins,Hope Miller,Michelle L Cassidy et al.
Kimberly R Robins et al.
Background: Primary central nervous system tumors (PCNST) are rare, understudied tumors for which knowledge of their clinical course, biology, physical, and psychological impact is limited. The National Cancer Institute's...
Prognostic associations of steroid use in patients with glioblastoma: A population-based study [0.03%]
胶质母细胞瘤患者使用类固醇的预后影响:基于人口的统计研究
Yasmin Abdel Moneim,Patrick Roth,Michael Weller et al.
Yasmin Abdel Moneim et al.
Background: Steroids are broadly used in patients with brain tumors. A possible detrimental association of corticosteroid treatment with outcome in patients with glioblastoma has been reported but not explored on a popula...